Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RaySearch Laboratories AB ( ($SE:RAY.B) ) has issued an announcement.
RaySearch Laboratories has released its 2025 annual report, detailing the audited financial statements, directors’ report, and a statutory sustainability report prepared under the earlier Swedish Annual Accounts Act, as the company is not yet subject to new reporting rules. The official report is compiled in Swedish using the European Single Electronic Format, with the English version serving as a non-authoritative translation.
The report outlines RaySearch’s business model, innovation strategy, market overview, and geographic reach, as well as corporate governance, risk management, and multi-year performance metrics. It also provides information on environmental, social, and business conduct matters alongside data on shares, shareholders, and alternative performance measures, offering stakeholders a comprehensive view of the company’s operational and strategic position in 2025.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Swedish medical technology company focused on advanced oncology software. Its primary products and solutions support radiation therapy planning and oncology workflows across global markets, with a strong emphasis on innovation, sustainability, and long-term value creation for healthcare providers and patients.
Average Trading Volume: 173,397
Technical Sentiment Signal: Hold
Current Market Cap: SEK6.78B
For a thorough assessment of RAY.B stock, go to TipRanks’ Stock Analysis page.